In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; Fredun Pharmaceuticals has informed that it enclosed Certificate dated January 02, 2023 received from the SEBI Registered Registrar and Share Transfer Agent (RTA) - Purva Sharegistry (India) for the quarter ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1903.25 |
| Dr. Reddys Labs. | 1376.00 |
| Cipla | 1460.80 |
| Zydus Lifesciences | 1128.70 |
| Lupin | 2466.25 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: